The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
University of Wisconsin researchers and collaborators recently published a feasibility study that focuses on limiting fetal growth restriction in nonhuman primates through nanoparticle injections of ...
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
The sentencing of 14 religious fanatics found to have killed a little girl west of Brisbane by depriving her of insulin will begin this morning.
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind ...
A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of ...
Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...
Cosmetic surgery has been an unlikely inspiration behind a cancer treatment discovery which could also help with diabetes ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Later, synthetic ‘human’ insulin was developed in 1978 and then ... such as the approval of Novo Nordisk’s Ozempic (semaglutide injection) and Eli Lilly’s Trulicity (dulaglutide).
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results